A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters
about
Amphetamine, past and present--a pharmacological and clinical perspectivePsychostimulants and cognition: a continuum of behavioral and cognitive activationRole of Dopamine Receptors in ADHD: A Systematic Meta-analysisA practical guide to the therapy of narcolepsy and hypersomnia syndromesHow addictive drugs disrupt presynaptic dopamine neurotransmissionNonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substratesSpontaneous inward opening of the dopamine transporter is triggered by PIP2-regulated dynamics of the N-terminusA Novel Heterocyclic Compound CE-104 Enhances Spatial Working Memory in the Radial Arm Maze in Rats and Modulates the Dopaminergic System.Making Sense of: Sensitization in SchizophreniaDuloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory studyVentral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine.R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice.The Sodium Channel β4 Auxiliary Subunit Selectively Controls Long-Term Depression in Core Nucleus Accumbens Medium Spiny Neurons.Insertion of tetracysteine motifs into dopamine transporter extracellular domains.Dopamine transporter trafficking: rapid response on demand.PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein.The N terminus of monoamine transporters is a lever required for the action of amphetaminesBiological substrates of addiction.Amphetamine-induced release of dopamine in primate prefrontal cortex and striatum: striking differences in magnitude and timecourseAmfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment optionsIn vivo amphetamine action is contingent on αCaMKIIPKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA effluxRegulation of monoamine transporters: Role of transporter phosphorylation.Practical use and risk of modafinil, a novel waking drug.Computational modeling of the N-terminus of the human dopamine transporter and its interaction with PIP2 -containing membranes.Drosophila melanogaster as a genetic model system to study neurotransmitter transporters.Behavioral cross-sensitization between DOCA-induced sodium appetite and cocaine-induced locomotor behavior.SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.PKCβ-dependent phosphorylation of the glycine transporter 1.Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.Does reverse transport of dopamine play a role in autism?Amphetamines, new psychoactive drugs and the monoamine transporter cycle.Brain Region-Specific Trafficking of the Dopamine Transporter.Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux.The solute carrier 6 family of transportersAdolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatmentsNecessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHDAmphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate
P2860
Q22241826-AA38618C-F4AF-4909-BB2F-0855D18415ABQ22242285-27E24188-BB05-4D30-8F5F-43D3C983C7C6Q22252576-46FF3DD4-53DC-44C6-8687-1AE2DB812D4EQ24623713-907F28EE-DA75-4A1D-9392-8C6DA87E6918Q24631269-10F8CE34-1567-4D34-89B1-C1B413BCADDAQ26853319-8F71B98C-FDE5-4638-9799-D875D3A465A1Q27300323-3041C6C2-A019-4BEC-9E37-9B1BB3353ACCQ27321436-045CC40C-38C4-493F-A9B2-6A32DD006998Q28077939-F713B6CF-3703-4577-B39E-386043048092Q28483370-BBD6C5CE-CB58-47D7-ABD3-AC6BFA3EDB99Q30475702-5F129F75-1597-4CC4-9773-88E8F7A6444DQ30483115-DD121E97-0D1F-4AD7-8E75-A1C38EDE01B8Q30838287-509B7CDD-BB52-4B0E-AD01-5A2AEAEA77EEQ33531756-F249E47E-2A52-493B-B5AB-C9E767B8AD74Q33654916-4A811DC2-EFDA-4FEB-8482-88083D6EDABFQ33773594-B77D285A-3D35-4720-BB3C-D1165B7B3565Q33796294-11BA159C-A36A-491E-86E2-026173F97AEBQ33835356-6BEEA1BD-040A-4358-9BB3-9A78747CE261Q34021079-D71BBC1A-1D70-46A3-86E4-36BE4A2FD684Q34286130-69B5F791-DA53-4044-93CE-5EED7C86070AQ34393113-A28D8E07-B125-4C29-8B22-3E2BEC89B102Q34523471-2C1F65B6-9E6A-4982-9475-DF6D8BD252CCQ34540543-E6A822FB-AE62-4A11-A29F-1C4EC528228AQ34636243-FD3C29A4-C2E1-4E23-B5F4-2AC77F5E44B4Q34668331-ADD653A6-9515-4381-9063-1D34F5CAE44AQ34690868-308652A8-EDEB-44DA-8BE4-66F51BF44232Q34905514-E6850118-C142-40BA-A189-B6CD04BDEF6AQ35150201-D47F794E-44AA-42ED-99A2-C3356D98BA5DQ35580965-6AF2AE7F-6D1A-4ABA-A08B-5891DAE94F69Q35661148-4C0984EE-252E-4885-B02C-1F96E2C5217AQ35795110-D2754093-BA0C-47BC-BDF2-6D1963645C20Q35853599-383473BC-9768-4819-BF1B-51AF28C931AEQ36064414-084708BA-87B6-48C0-B54F-A0D2B6D00133Q36215945-ED72104E-29CF-41A8-ACB2-FFCE83F1CD06Q36346899-BBD36938-9261-4984-A619-89B018CBA3FEQ36372705-86D3894B-A3A6-4D83-94EE-9C200DEF6104Q36508575-EA6301A6-1C8F-49DA-8D67-B52D7EE1986EQ36681100-93D0725B-79DA-4B47-A0E8-7A581F557C43Q36892982-6AE87721-3C7B-4B14-80FA-499B8504C43FQ37010694-DB81F251-C99B-460F-BEBA-13228BD2D965
P2860
A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A closer look at amphetamine-i ...... nd norepinephrine transporters
@en
A closer look at amphetamine-i ...... d norepinephrine transporters.
@nl
type
label
A closer look at amphetamine-i ...... nd norepinephrine transporters
@en
A closer look at amphetamine-i ...... d norepinephrine transporters.
@nl
prefLabel
A closer look at amphetamine-i ...... nd norepinephrine transporters
@en
A closer look at amphetamine-i ...... d norepinephrine transporters.
@nl
P2860
P1476
A closer look at amphetamine-i ...... nd norepinephrine transporters
@en
P2093
P2860
P2888
P356
10.1007/S12035-009-8053-4
P577
2009-02-06T00:00:00Z